1. Home
  2. NFJ vs ENOV Comparison

NFJ vs ENOV Comparison

Compare NFJ & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NFJ

Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest

HOLD

Current Price

$14.79

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Enovis Corporation

ENOV

Enovis Corporation

HOLD

Current Price

$23.57

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NFJ
ENOV
Founded
2005
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Fluid Controls
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
NFJ
ENOV
Price
$14.79
$23.57
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
$47.38
AVG Volume (30 Days)
156.1K
1.1M
Earning Date
01-01-0001
05-07-2026
Dividend Yield
9.01%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$6.36
Revenue Next Year
N/A
$5.31
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.00
$20.82
52 Week High
$15.13
$36.82

Technical Indicators

Market Signals
Indicator
NFJ
ENOV
Relative Strength Index (RSI) 58.38 48.28
Support Level $12.70 $21.52
Resistance Level N/A $23.57
Average True Range (ATR) 0.17 1.17
MACD -0.00 -0.21
Stochastic Oscillator 65.28 45.45

Price Performance

Historical Comparison
NFJ
ENOV

About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest

Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. The primary investment objective of the company is to seek current income and gains, with a secondary objective of long-term capital appreciation. It pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.

About ENOV Enovis Corporation

Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.

Share on Social Networks: